Krebs Biochemicals & Industries Limited
Krebs Biochemicals & Industries Limited has issued a regulatory intimation to BSE Limited and National Stock Exchange of India Ltd regarding an upcoming board meeting.
The Board of Directors meeting is scheduled to be held on Thursday, October 29, 2026. The primary agenda is to consider and adopt the company's unaudited financial results for the second quarter and half year ended September 30, 2026.
The company had previously informed via letter dated September 21, 2026 about the trading window closure for insiders as defined under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window remains closed from the closure of business hours on September 30, 2026 until 48 hours after the declaration of the company's unaudited financial results for Q2 and half year ended September 30, 2026.